Routine

Diabetic peripheral neuropathy

neuropathy · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Length-dependent distal symmetrical polyneuropathy from chronic hyperglycaemia, presenting with numbness, burning pain and loss of protective sensation. It is the dominant risk factor for foot ulceration and amputation.

Red flags

  • New foot ulcer, deformity or Charcot changes
  • Rapidly progressive or asymmetrical weakness
  • Motor-predominant deficit suggesting alternative diagnosis
  • Autonomic instability (severe postural hypotension, gastroparesis)

Assessment

Differential diagnosis

  • Alcoholic/nutritional (B12, thiamine) neuropathy
  • Chronic inflammatory demyelinating polyneuropathy
  • Hypothyroid neuropathy
  • Monoclonal gammopathy/amyloid neuropathy
  • Lumbar radiculopathy
  • Drug-induced neuropathy

Investigations

  • 10g monofilament and 128 Hz tuning fork/vibration testing
  • Ankle reflexes and pinprick sensation
  • HbA1c and fasting glucose
  • B12, folate, TSH, U&E and serum protein electrophoresis to exclude mimics
  • Nerve conduction studies only if atypical (asymmetry, motor-predominant, rapid onset)

Management

  • Confirm distal symmetrical pattern and exclude non-diabetic causes
  • Optimise glycaemic control (strongest disease-modifying effect, especially in type 1)
  • Address cardiovascular risk: blood pressure, lipids, smoking cessation
  • Assess and document loss of protective sensation and stratify foot risk
  • Start first-line neuropathic pain agent and titrate to effect
  • Rotate or combine agents if inadequate response after adequate trial
  • Provide foot care education, appropriate footwear and podiatry referral
  • Screen for autonomic features (postural drop, gastroparesis, erectile dysfunction)
  • Review response, adherence and mood at follow-up

Drugs & doses

Amitriptyline 10-25 mg PO nocte, titrate to 75 mg
Duloxetine 30 mg PO once daily, up to 60-120 mg
Pregabalin 75 mg PO twice daily, up to 300 mg twice daily
Gabapentin 300 mg PO, titrate to 1200 mg three times daily
Capsaicin 0.075% cream topically for localised pain

Disposition

Primary care/diabetes clinic with podiatry; refer to pain or neurology services for refractory pain or atypical features, and urgently for any new foot complication.

Complications & pitfalls

  • Foot ulceration and amputation
  • Charcot neuroarthropathy
  • Falls and fractures
  • Chronic pain, sleep disturbance and depression

Exam pearls

  • Loss of the 10g monofilament predicts ulcer risk better than symptoms
  • Glucose control prevents progression far more in type 1 than type 2 disease
  • Combine agents from different classes before abandoning treatment
  • Always check B12, especially in metformin users, before attributing to diabetes

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.